New drug offers hope for Alzheimer's victims
[2008-7-23]
Tag: drug
MIAMI, Florida (WFOR) - As many as five-million Americans are living with Alzheimer's disease. Alzheimer's destroys brain cells, causing problems with memory, thinking and behavior severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time, and it is fatal: it is now the seventh-leading cause of death in the United States.
Bapineuzumab has been touted by its developers as potentially the first Alzheimer's drug to slow progression of the disease, rather than just treat symptoms.
In a recent study, released in mid-June, half of the 240 Alzheimer's patients were given the drug while the other half were given a placebo and the researchers say although the drug did not reach statistical goals it did prove to be relatively effective when given to patients diagnosed with the degenerative brain disorder.
The interim results showed that patients given the new drug showed less loss of brain volume among treated patients compared with those given a placebo.
Bonnie Lowe is 89 years old and suffers from Alzheimer's, which is beginning to take a toll on her memory.
She's taking a shot on the experimental medication, which is basically an Alzheimer's vaccine.
MIAMI, Florida (WFOR) - As many as five-million Americans are living with Alzheimer's disease. Alzheimer's destroys brain cells, causing problems with memory, thinking and behavior severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time, and it is fatal: it is now the seventh-leading cause of death in the United States.
Bapineuzumab has been touted by its developers as potentially the first Alzheimer's drug to slow progression of the disease, rather than just treat symptoms.
In a recent study, released in mid-June, half of the 240 Alzheimer's patients were given the drug while the other half were given a placebo and the researchers say although the drug did not reach statistical goals it did prove to be relatively effective when given to patients diagnosed with the degenerative brain disorder.
The interim results showed that patients given the new drug showed less loss of brain volume among treated patients compared with those given a placebo.
Bonnie Lowe is 89 years old and suffers from Alzheimer's, which is beginning to take a toll on her memory.
She's taking a shot on the experimental medication, which is basically an Alzheimer's vaccine.
Related News »
In Focus »
footwear exports
Last month, European footwear manufacturers proposed extending anti-dumping measures against ..
B2B Keywords:
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product



